newsfilter
← Latest News
GlobeNewswire·

Heron Therapeutics to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026

CARY, N.C., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the Company will host a